Low Dose Ruxolitinib in Indian Haplo-Identical Transplant Patients with Steroid Refractory Acute Graft Versus Host Disease

被引:0
|
作者
Kumar, Kishore [1 ]
Prabhu, Durai [2 ]
Kandan, Mani [3 ]
Thooran, Sen [3 ]
Subash, Chezhian [1 ]
机构
[1] MIOT Inst Haematol, Chennai, Tamil Nadu, India
[2] MIOT Int Hosp, Chennai, Tamil Nadu, India
[3] MIOT, Chennai, Tamil Nadu, India
关键词
D O I
10.1182/blood-2022-157269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:12893 / 12894
页数:2
相关论文
共 50 条
  • [21] Ruxolitinib for steroid-refractory graft-versus-host disease: A case series
    Lancman, Guido
    Coltoff, Alexander
    Steinberg, Amir
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 611 - 613
  • [22] Abatacept-based Graft-Versus-Host Disease Prophylaxis in Haplo-identical Hematopoietic Cell Transplant in a High-risk Cohort
    Raffa, Enass H.
    Srinivasan, Anand
    Wall, Donna A.
    Schechter, Tal
    Ali, Muhammad
    Krueger, Joerg
    Chiang, Kuang-Yueh
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (07) : 383 - 387
  • [23] Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease
    Murray, Alistair
    Linn, Swe Mar
    Yu, Benoit
    Novitzky-Basso, Igor
    Mattsson, Jonas
    Kennah, Michael
    Elemary, Mohamed
    White, Jennifer
    Lemieux, Christopher
    Jamani, Kareem
    Kim, Dennis Dong Hwan
    BONE MARROW TRANSPLANTATION, 2024, 59 (06) : 759 - 764
  • [24] Treatment of steroid-refractory acute and chronic graft-versus-host disease with ruxolitinib in adults and children
    Moiseev, Ivan
    Morozova, Elena
    Barabanshikova, Maria
    Kozlov, Andrey
    Rudakova, Tatyana
    Klimova, Olesya
    Tcvetkov, Nikolai
    Pirogova, Olga
    Borzenkova, Evgeniya
    Kozhokar, Polina
    Ekushev, Kirill
    Paina, Olesya
    Bykova, Tatyana
    Darskaya, Elena
    Bondarenko, Sergey
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2018, 53 : 461 - 462
  • [25] Ruxolitinib Treatment for Steroid Refractory ACUTE and Chronic GRAFT Versus Host Disease in Children: Clinical and Immunological Results
    Gonzalez Vicent, Marta
    Molina, Blanca
    Gonzalez de Pablo, Jesus
    Castillo, Ana
    Angel Diaz, Miguel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [26] Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Disease: A Single Centre Retrospective Study
    Suo, Yuan
    Liu, Jiapei
    Sun, Yiming
    Wu, Qiaoyuan
    Jin, Hua
    Liu, Qifa
    BLOOD, 2021, 138
  • [27] USE OF RUXOLITINIB IN STEROID DEPENDENT/REFRACTORY ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A SINGLE CENTRE EXPERIENCE
    Galopoulos, Dimitris
    Irvine, David
    Parker, Anne
    McQuaker, Grant
    Latif, Anne-Louise
    Holroyd, Ailsa
    Welsh, Lorna
    Clark, Andrew
    BONE MARROW TRANSPLANTATION, 2024, 59 : 338 - 339
  • [28] FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Przepiorka, Donna
    Luo, Lola
    Subramaniam, Sriram
    Qiu, Junshan
    Gudi, Ramadevi
    Cunningham, Lea C.
    Nie, Lei
    Leong, Ruby
    Ma, Lian
    Sheth, Christopher
    Deisseroth, Albert
    Goldberg, Kirsten B.
    Blumenthal, Gideon M.
    Pazdur, Richard
    ONCOLOGIST, 2020, 25 (02): : E328 - E334
  • [29] Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
    Zeiser, Robert
    von Bubnoff, Nikolas
    Butler, Jason
    Mohty, Mohamad
    Niederwieser, Dietger
    Or, Reuven
    Szer, Jeff
    Wagner, Eva M.
    Zuckerman, Tsila
    Mahuzier, Bruyere
    Xu, Judith
    Wilke, Celine
    Gandhi, Kunal K.
    Socie, Gerard
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19): : 1800 - 1810
  • [30] Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research
    Fan, Zhiping
    Deng, Lan
    Li, Xudong
    Zhang, Qing
    Xuan, Li
    Huang, Fen
    Lin, Ren
    Jin, Hua
    Xu, Na
    Shi, Pengcheng
    Wang, Zhixiang
    Ye, Jieyu
    Jiang, Ling
    Sun, Jing
    Liu, Qifa
    BLOOD, 2018, 132